MTOR and asthma: A previous study showed that mTOR signaling was significantly activated in patients with asthma onset (Zhang et al., 2017), and that the inhibition of mTOR by rapamycin remarkably attenuated airway hyper-reactivity and inflammation in asthmatic mice (Mushaben et al., 2011).